These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 13150331)
1. Studies of the mechanism of enhancement by accelerant factor (s) of a transplantable mouse tumor Z8352. SHEAR HH; SYVERTON JT; BITTNER JJ Cancer Res; 1954 Mar; 14(3):183-9. PubMed ID: 13150331 [No Abstract] [Full Text] [Related]
2. Properties of the accelerant factor (s) for a transplantable mouse mammary tumor, Z8352. SHEAR HH; SYVERTON JT; BITTNER JJ Cancer Res; 1954 Mar; 14(3):175-82. PubMed ID: 13150330 [No Abstract] [Full Text] [Related]
3. Studies on the mechanism of cortisone-induced metastases of transplantable mouse tumors. POMEROY TC Cancer Res; 1954 Mar; 14(3):201-4. PubMed ID: 13150334 [No Abstract] [Full Text] [Related]
4. Induced susceptibility and resistance to an indigenous transplantable mouse tumor with autolyzed and alcohol-killed tumor tissue. PRINCE JE; MORGAN CM; FARDON JC; NUTINI LG; DUARTE AG Cancer Res; 1958 Aug; 18(7):760-3. PubMed ID: 13573339 [No Abstract] [Full Text] [Related]
5. Further studies on metastasis of a transplantable mouse mammary carcinoma after roentgen irradiation. VON ESSEN CF; KAPLAN HS J Natl Cancer Inst; 1952 Feb; 12(4):883-92. PubMed ID: 14908552 [No Abstract] [Full Text] [Related]
6. Studies on a transplantable chicken lymphoma (RPL-12) I. Pathological changes following transplantation of the tumor. LOVE R; SHARPLESS GR Cancer Res; 1953 Dec; 13(12):869-75. PubMed ID: 13116126 [No Abstract] [Full Text] [Related]
7. Pathologic studies of Friend virus leukemia and the development of a transplantable tumor in BALB/c mice. DAWSON PJ; FIELDSTEEL AH; BOSTICK WL Cancer Res; 1963 Mar; 23():349-54. PubMed ID: 14025603 [No Abstract] [Full Text] [Related]
8. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)]. Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782 [TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of action of 6-uracil methyl sulfone in mouse Ehrlich ascites tumor cells in vitro. PRUSOFF WH Cancer Res; 1958 Jun; 18(5):603-7. PubMed ID: 13547058 [No Abstract] [Full Text] [Related]
10. A transplantable mast-cell neoplasm in the mouse. DUNN TB; POTTER M J Natl Cancer Inst; 1957 Apr; 18(4):587-601. PubMed ID: 13416911 [No Abstract] [Full Text] [Related]
11. [Strain of transplantable mouse sarcoma AK & its ascitic variant]. KOMAR VE Vopr Onkol; 1958; 4(2):207-10. PubMed ID: 13558007 [No Abstract] [Full Text] [Related]
12. The effect of cortisol on the growth of a transplantable mouse fibrosarcoma. NANDI J; BERN HA Cancer Res; 1958 Aug; 18(7):790-5. PubMed ID: 13573344 [No Abstract] [Full Text] [Related]
13. [Mitotic activity of cells in certain transplantable mouse sarcomas]. KRAVCHENKO AI Vopr Onkol; 1959; 5(3):329-32. PubMed ID: 13659881 [No Abstract] [Full Text] [Related]
14. Observations on transplantable osteogenic sarcoma (C3H mouse) exposed to anterior pituitary growth hormone. BOVILL EG Stanford Med Bull; 1959 Feb; 17(1):26-7. PubMed ID: 13635205 [No Abstract] [Full Text] [Related]
15. [LYMPHNODE REACTION AFTER TRANSPLANTABLE TUMOR HOMOGRAFT (GU'ERIN TUMOR T 8) IN THE RAT]. MASSE L; MASSE C; CHASSAIGNE JP Bull Acad Natl Med; 1963 Jun; 147():499-504. PubMed ID: 14054205 [No Abstract] [Full Text] [Related]
16. Transplantable osteogenic sarcoma of the mouse exposed to vitamin A intoxication and vitamin D deficiency. BOVILL EG Surg Forum; 1957; 8():554-7. PubMed ID: 13529680 [No Abstract] [Full Text] [Related]
17. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin]. Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366 [TBL] [Abstract][Full Text] [Related]
18. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451 [TBL] [Abstract][Full Text] [Related]
19. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. Li J; Hu P; Khawli LA; Epstein AL Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000 [TBL] [Abstract][Full Text] [Related]
20. Host responses to a transplantable "ascitic" tumor. SIEGLER R; KOPROWSKA I Cancer Res; 1962 Dec; 22():1278-83. PubMed ID: 13988977 [No Abstract] [Full Text] [Related] [Next] [New Search]